News

Google News
pharmadispatch. com > news > ausbiotech-launches-survey-in-response-to-budgets-blind-spot-on-rd-impact

Aus Biotech launches survey in response to Budget's 'blind spot' on R&D impact - Bio Pharma Dispatch

3+ hour, 45+ min ago  (131+ words) Aus Biotech launches survey in response to Budget's 'blind spot' on R&D impact Pharma Dispatch Aus Biotech launches survey in response to Budget's 'blind spot' on R&D impact Aus Biotech has warned that last week's 2026-27 Budget offers a…...

Symbols: btc-usd
Startup Hub. ai
startuphub. ai > startups > narya-bio-narya-ai

Narya Bio " $55 M Raised, Investors, Team & Alternatives

17+ hour, 26+ min ago  (86+ words) Narya Bio is developing novel therapeutic antibodies for challenging diseases. Narya Bio is a biotechnology company focused on developing next-generation therapeutic antibodies. They leverage advanced computational and biological approaches to design antibodies with improved efficacy and safety profiles for diseases…...

Symbols: nasdaq:nktr
Google News
startuphub. ai > startups > khosen-bio-khosenbio-com

Khosen Bio " $10 M Raised " Reviews & Alternatives

17+ hour, 25+ min ago  (104+ words) Khosen Bio " $10 M Raised, Investors, Team & Alternatives Startup Hub. ai Developing novel therapeutic antibodies for challenging diseases. What does Khosen Bio do? Khosen Bio is a biotechnology company focused on the discovery and development of innovative antibody-based therapeutics. They aim…...

Symbols: nasdaq:krys
facilitiesmanagement-now. com
facilitiesmanagement-now. com-now. com

Energy & Talent: Inside Mitie's "26m Astra Zeneca Contract

8+ hour, 50+ min ago  (11+ words) facilitiesmanagement-now. com...

Symbols: btc-usd
@China Daily App
global. chinadaily. com. cn > a > 202505 > 09 > WS681d5be0a310a04af22be4b3. html

Swiss drugmaker to build new manufacturing facility in Shanghai

16+ hour, 21+ min ago  (438+ words) SHANGHAI - Swiss pharmaceutical giant Roche has announced plans to invest 2. 04 billion yuan ($283 million) in building a new biopharmaceutical manufacturing facility in Shanghai's Pudong New Area, strengthening its localization strategy in the Chinese market. The new biologics manufacturing site, in Zhangjiang…...

Symbols: btc-usd
Trading View
tradingview. com > news > reuters. com, 2026: newsml_L4 N42100 Z: 0-bio-sincerity-pharma-tech-s-trading-to-halt-pending-ownership-change

Bio-Sincerity Pharma-Tech's Trading To Halt Pending Ownership Change

15+ hour, 45+ min ago  (25+ words) Trading View Bio-Sincerity Pharma-Tech's Trading To Halt Pending Ownership Change More news from Reuters...

Symbols: nasdaq:tech,nasdaq:dmlp,nasdaq:msft,nasdaq:googl,otc:cubtd,nasdaq:cytk
Market Screener
marketscreener. com > news > certain-warrants-of-parazero-technologies-ltd-are-subject-to-a-lock-up-agreement-ending-on-24-may-2-ce7f5adcde8df121

Certain Warrants of Para Zero Technologies Ltd. are subject to a Lock-Up Agreement Ending on 24-MAY-2026.

22+ hour, 50+ min ago  (67+ words) marketscreener. com Certain Warrants of Para Zero Technologies Ltd. are subject to a Lock-Up Agreement Ending on 24-MAY-2026. Published on 05/23/2026 at 08: 36 pm EDT Latest news about Para Zero Technologies Ltd. Chart Para Zero Technologies Ltd. Income Statement and Estimates Annual…...

Symbols: nasdaq:srta,nasdaq:srtaw
Oduu
harianbasis. co > en > bristol-myers-squibb-boosts-growth-anthropic-ai

Bristol-Myers Squibb Boosts Growth Potential with Anthropic AI Strategy

20+ hour, 32+ min ago  (273+ words) Under the agreement details released on May 20, Bristol-Myers Squibb will deploy Anthropic's Claude AI model across its core operations. The deployment spans clinical development, manufacturing, research, commercial, and corporate functions, granting access to more than 30, 000 employees. The technology integration targets…...

Symbols: nyse:bmy,nyse:lly,btc-usd
Barchart. com
barchart. com > story > news > 2105217 > platinum-biologics-advances-quality-standards-in-the-regenerative-medicine-supply-chain

Platinum Biologics Advances Quality Standards in the Regenerative Medicine Supply Chain

23+ hour, 45+ min ago  (276+ words) As regenerative medicine continues to attract interest from physicians in orthopedics, pain management, sports medicine, aesthetics, and related specialties, quality control has become a central concern. Providers evaluating biologic products increasingly look beyond pricing and availability to assess how products…...

Symbols: nasdaq:plrz
ACCESSWIRE Newsroom
accessnewswire. com > newsroom > en > consumer-and-retail-products > leviapatch-review-dont-buy-that-%22best-glp-1-patch-for-weight-loss%22-bef-1170269

Levia Patch Review: Don't Buy That "Best GLP-1 Patch for Weight Loss" Before Reading This Plant-Based Consumer Report First!

22+ hour, 5+ min ago  (1628+ words) Saturday, 23 May 2026 07: 15 PM Levia Patch GLP-1 Patch Review 2026: What the Research Shows, What the Brand Claims, and What Every Buyer Should Verify First If you've landed here, you've probably already seen the mess of overclaiming in the GLP-1 patch space....

Symbols: btc-usd